Literature DB >> 1941027

Likelihood ratios with confidence: sample size estimation for diagnostic test studies.

D L Simel1, G P Samsa, D B Matchar.   

Abstract

Confidence intervals are important summary measures that provide useful information from clinical investigations, especially when comparing data from different populations or sites. Studies of a diagnostic test should include both point estimates and confidence intervals for the tests' sensitivity and specificity. Equally important measures of a test's efficiency are likelihood ratios at each test outcome level. We present a method for calculating likelihood ratio confidence intervals for tests that have positive or negative results, tests with non-positive/non-negative results, and tests reported on an ordinal outcome scale. In addition, we demonstrate a sample size estimation procedure for diagnostic test studies based on the desired likelihood ratio confidence interval. The renewed interest in confidence intervals in the medical literature is important, and should be extended to studies analyzing diagnostic tests.

Mesh:

Year:  1991        PMID: 1941027     DOI: 10.1016/0895-4356(91)90128-v

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  218 in total

1.  Comparison of stool immunoassay with standard methods for detecting Helicobacter pylori infection.

Authors:  F Lehmann; J Drewe; L Terracciano; R Stuber; R Frei; C Beglinger
Journal:  BMJ       Date:  1999-11-27

Review 2.  How could pathologists improve the initial diagnosis of colitis? Evidence from an international workshop.

Authors:  E Bentley; D Jenkins; F Campbell; B Warren
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

3.  A reformulated spherule-derived coccidioidin (Spherusol) to detect delayed-type hypersensitivity in coccidioidomycosis.

Authors:  Royce Johnson; Steven M Kernerman; Bradley G Sawtelle; Suresh C Rastogi; H Stewart Nielsen; Neil M Ampel
Journal:  Mycopathologia       Date:  2012-06-06       Impact factor: 2.574

4.  Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns.

Authors:  Suresh B Boppana; Shannon A Ross; Masako Shimamura; April L Palmer; Amina Ahmed; Marian G Michaels; Pablo J Sánchez; David I Bernstein; Robert W Tolan; Zdenek Novak; Nazma Chowdhury; William J Britt; Karen B Fowler
Journal:  N Engl J Med       Date:  2011-06-02       Impact factor: 91.245

5.  MR imaging in the assessment of residual tumour following inadequate primary excision of soft tissue sarcomas.

Authors:  A M Davies; A Mehr; S Parsonage; N Evans; R J Grimer; P B Pynsent
Journal:  Eur Radiol       Date:  2003-10-14       Impact factor: 5.315

6.  The use of infrared thermometry for the detection of fever.

Authors:  Alastair D Hay; Tim J Peters; Andrew Wilson; Tom Fahey
Journal:  Br J Gen Pract       Date:  2004-06       Impact factor: 5.386

7.  Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis--a meta-analysis.

Authors:  Gunnar Tomasson; Peter C Grayson; Alfred D Mahr; Michael Lavalley; Peter A Merkel
Journal:  Rheumatology (Oxford)       Date:  2011-10-29       Impact factor: 7.580

Review 8.  A concise evidence-based physical examination for diagnosis of acromioclavicular joint pathology: a systematic review.

Authors:  Michael K Krill; Samuel Rosas; KiHyun Kwon; Andrew Dakkak; Benedict U Nwachukwu; Frank McCormick
Journal:  Phys Sportsmed       Date:  2017-12-13       Impact factor: 2.241

9.  Diagnostic performance of a rapid antigen test for RSV in comparison with a 19-valent multiplex RT-PCR ELISA in children with acute respiratory tract infections.

Authors:  Heike Schützle; Josef Weigl; Wolfram Puppe; Johannes Forster; Reinhard Berner
Journal:  Eur J Pediatr       Date:  2007-09-02       Impact factor: 3.183

10.  Persistent infection with human papillomavirus 16 or 18 is strongly linked with high-grade cervical disease.

Authors:  David Radley; Alfred Saah; Margaret Stanley
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.